485 related articles for article (PubMed ID: 15165749)
1. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
Rangwala SM; Lazar MA
Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
[TBL] [Abstract][Full Text] [Related]
2. PPAR gamma gene--a review.
Janani C; Ranjitha Kumari BD
Diabetes Metab Syndr; 2015; 9(1):46-50. PubMed ID: 25450819
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity.
Spiegelman BM
Eur J Med Res; 1997 Nov; 2(11):457-64. PubMed ID: 9385114
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
[TBL] [Abstract][Full Text] [Related]
5. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
Andrééva-Gatéva P
Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
[TBL] [Abstract][Full Text] [Related]
6. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
Uauy R; Martínez JI; Rojas CV
Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors as molecular targets for drug therapy.
Sridhar GR
J Assoc Physicians India; 2003 Jan; 51():49-52. PubMed ID: 12693455
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma and metabolic disease.
Willson TM; Lambert MH; Kliewer SA
Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411
[TBL] [Abstract][Full Text] [Related]
9. PPAR gamma, 10 years later.
Lazar MA
Biochimie; 2005 Jan; 87(1):9-13. PubMed ID: 15733730
[TBL] [Abstract][Full Text] [Related]
10. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
11. [PPAR gamma--the master of thrifty genes].
Chang YS; Fang FD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):315-20. PubMed ID: 12905643
[TBL] [Abstract][Full Text] [Related]
12. PPARs and the complex journey to obesity.
Evans RM; Barish GD; Wang YX
Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance.
Guo L; Tabrizchi R
Pharmacol Ther; 2006 Jul; 111(1):145-73. PubMed ID: 16305809
[TBL] [Abstract][Full Text] [Related]
14. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
Gross B; Staels B
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):687-710. PubMed ID: 18054742
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
Gurnell M
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
17. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
18. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
Moller DE; Berger JP
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
[TBL] [Abstract][Full Text] [Related]
19. The role of the orphan nuclear receptor Rev-Erb alpha in adipocyte differentiation and function.
Laitinen S; Fontaine C; Fruchart JC; Staels B
Biochimie; 2005 Jan; 87(1):21-5. PubMed ID: 15733732
[TBL] [Abstract][Full Text] [Related]
20. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]